SORARU', GIANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.999
AS - Asia 8.993
EU - Europa 5.003
AF - Africa 1.580
SA - Sud America 1.400
OC - Oceania 162
Continente sconosciuto - Info sul continente non disponibili 74
Totale 34.211
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.140
SG - Singapore 2.833
CN - Cina 1.571
IT - Italia 1.477
VN - Vietnam 1.130
HK - Hong Kong 992
BR - Brasile 830
FR - Francia 389
FI - Finlandia 372
DE - Germania 349
IN - India 311
SE - Svezia 260
GB - Regno Unito 256
BD - Bangladesh 235
PL - Polonia 198
RU - Federazione Russa 161
UA - Ucraina 156
NL - Olanda 154
IQ - Iraq 146
TR - Turchia 137
JP - Giappone 124
AR - Argentina 117
ES - Italia 106
PH - Filippine 106
CA - Canada 105
ID - Indonesia 104
MX - Messico 100
PK - Pakistan 100
SA - Arabia Saudita 99
IE - Irlanda 83
ZA - Sudafrica 76
BJ - Benin 73
CO - Colombia 68
KR - Corea 68
AT - Austria 66
EC - Ecuador 63
MY - Malesia 63
UZ - Uzbekistan 63
ET - Etiopia 62
CH - Svizzera 58
EG - Egitto 58
KE - Kenya 56
TH - Thailandia 56
VE - Venezuela 54
PY - Paraguay 52
CI - Costa d'Avorio 51
DZ - Algeria 51
JO - Giordania 51
AE - Emirati Arabi Uniti 50
CZ - Repubblica Ceca 50
MA - Marocco 50
CU - Cuba 49
KG - Kirghizistan 49
UY - Uruguay 49
PE - Perù 48
AL - Albania 46
CL - Cile 46
KZ - Kazakistan 46
LB - Libano 46
SN - Senegal 46
CR - Costa Rica 45
GH - Ghana 45
NO - Norvegia 45
NP - Nepal 45
RO - Romania 45
AO - Angola 44
PA - Panama 44
UG - Uganda 44
DK - Danimarca 43
LU - Lussemburgo 43
MR - Mauritania 43
PT - Portogallo 43
RS - Serbia 43
AM - Armenia 42
CV - Capo Verde 42
HN - Honduras 42
PR - Porto Rico 42
SI - Slovenia 42
AZ - Azerbaigian 41
CY - Cipro 41
JM - Giamaica 41
LA - Repubblica Popolare Democratica del Laos 41
TT - Trinidad e Tobago 41
BA - Bosnia-Erzegovina 40
DO - Repubblica Dominicana 40
KH - Cambogia 40
BB - Barbados 39
BO - Bolivia 39
HU - Ungheria 39
PS - Palestinian Territory 39
YT - Mayotte 39
BG - Bulgaria 38
BY - Bielorussia 38
GA - Gabon 38
GE - Georgia 38
GM - Gambi 38
GN - Guinea 38
IL - Israele 38
SK - Slovacchia (Repubblica Slovacca) 38
TJ - Tagikistan 38
Totale 32.449
Salva come PNG Salva come JPEG
Città #
Ashburn 2.012
Fairfield 1.810
Singapore 1.676
San Jose 1.550
Woodbridge 1.307
Houston 1.169
Hong Kong 918
Ann Arbor 897
Seattle 745
Wilmington 622
Chandler 618
Cambridge 597
Ho Chi Minh City 351
Jacksonville 325
Padua 283
Beijing 273
Los Angeles 260
Boardman 243
Hanoi 234
Lauterbourg 200
San Diego 195
Princeton 190
Santa Clara 190
Padova 182
New York 166
Helsinki 159
Medford 125
Bytom 121
Milan 121
Roxbury 108
Council Bluffs 105
Des Moines 105
Munich 101
Chicago 88
Nanjing 85
Dong Ket 83
São Paulo 78
The Dalles 77
Tokyo 74
Cotonou 71
Orem 71
Dublin 69
Guangzhou 62
Buffalo 60
London 60
Rome 54
Tashkent 53
Abidjan 51
Atlanta 50
Baghdad 50
Hefei 50
Addis Ababa 49
Warsaw 49
Amman 48
Dallas 48
Nairobi 48
Nuremberg 48
Dakar 46
Chennai 45
Frankfurt am Main 45
Kampala 44
Phoenix 44
Treviso 43
Turku 43
Haiphong 42
Jeddah 42
Bishkek 41
Havana 41
Montreal 40
Vicenza 40
Baku 39
Panama City 39
Washington 39
Bridgetown 38
Conakry 38
Da Nang 37
Dushanbe 37
Istanbul 37
Libreville 37
Nouakchott 37
Piscataway 37
Catania 36
Montevideo 36
San José 36
Vientiane 36
Accra 35
Luanda 35
Yerevan 35
Vienna 34
Denver 33
Lahore 33
Noumea 33
Phnom Penh 33
Praia 33
Bamako 32
Lappeenranta 31
Tianjin 31
Kingston 30
Lusaka 30
Podgorica 30
Totale 21.037
Salva come PNG Salva come JPEG
Nome #
271st ENMC international workshop: Towards a unifying effort to fight Kennedy's disease. 20-22 October 2023, Hoofddorp, Netherlands 684
Onset Manifestations of Spinal and Bulbar Muscular Atrophy (Kennedy’s Disease) 568
Screening of the PFN1 gene in sporadic amyotrophic lateral sclerosis and in frontotemporal dementia 453
Non-neural phenotype of spinal and bulbar muscular atrophy: Results from a large cohort of Italian patients 357
Increased mitophagy in the skeletal muscle of spinal and bulbar muscular atrophy patients 342
Polyglutamine-Expanded Androgen Receptor Alteration of Skeletal Muscle Homeostasis and Myonuclear Aggregation Are Affected by Sex, Age and Muscle Metabolism 316
Italian version of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS): validation and longitudinal performance 312
210th ENMC International Workshop: Research and clinical management of patients with spinal and bulbar muscular atrophy, 27-29 March, 2015, Naarden, The Netherlands 308
Unimpaired Neuropsychological Performance and Enhanced Memory Recall in Patients with Sbma: A Large Sample Comparative Study. 299
Glycolytic-to-oxidative fiber-type switch and mTOR signaling activation are early-onset features of SBMA muscle modified by high-fat diet 299
Functional changes in Becker muscular dystrophy: Implications for clinical trials in dystrophinopathies 295
SPP1 genotype and glucocorticoid treatment modify osteopontin expression in Duchenne muscular dystrophy cells 295
Evaluation of peripherin in biofluids of patients with motor neuron diseases 285
Improving the knowledge of amyotrophic lateral sclerosis genetics: novel SOD1 and FUS variants. 279
Genetic modifiers of Duchenne muscular dystrophy and dilated cardiomyopathy 269
Muscle MRI and functional outcome measures in Becker muscular dystrophy 264
Defective excitation-contraction coupling and mitochondrial respiration precede mitochondrial Ca2+ accumulation in spinobulbar muscular atrophy skeletal muscle 262
Hypnosis-based psychodynamic treatment in ALS: a longitudinal study on patients and their caregivers 262
Parkinson-like features in ALS with predominant upper motor neuron involvement 256
Brain involvement in myotonic dystrophies: neuroimaging and neuropsychological comparative study in DM1 and DM2 255
Theory of mind, empathy and neuropsychological functioning in X-linked Spinal and Bulbar Muscular Atrophy: a controlled study of 20 patients 251
Cardiomyopathy in patients with POMT1-related congenital and limb-girdle muscular dystrophy. 251
No effect of AR polyG polymorphism on spinal and bulbar muscular atrophy phenotype 251
TUBA4A gene analysis in sporadic amyotrophic lateral sclerosis: identification of novel mutations 250
ExoBand, A Passive Wearable Device as a Walking Aid in Neuromuscular Patients: First Quantitative Assessment 249
New FIG4 gene mutations causing aggressive ALS 249
Enhanced neural empathic responses in patients with Spino-Bulbar Muscular Atrophy: An electrophysiological study 246
Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease 242
Deep characterization of females with heterozygous Duchenne muscular dystrophy mutations 238
Clinical and molecular study in a long-surviving patient with MLASA syndrome due to novel PUS1 mutations 237
LSD1/PRMT6-targeting gene therapy to attenuate androgen receptor toxic gain-of-function ameliorates spinobulbar muscular atrophy phenotypes in flies and mice 235
Specific numerical processing impairment in ALS patients 231
Analysis of hnRNPA1, A2/B1, and A3 genes in patients with amyotrophic lateral sclerosis. 231
TGFB2R but not SPP1 genotype modulates osteopontin expression in Duchenne muscular dystrophy muscle. 229
Progress in enzyme replacement therapy in glycogen storage disease type II 228
C9ORF72 repeat expansion in a large Italian ALS cohort: Evidence of a founder effect 228
Impact on children of a parent with ALS: a case-control study 226
ALS risk but not phenotype is affected by ataxin-2 intermediate length polyglutamine expansion 224
Quality of life assessment in adult spinal muscular atrophy patients treated with nusinersen 222
The clinical spectrum of CASQ1-related myopathy 221
Female gender doubles executive dysfunction risk in ALS: a case-control study in 165 patients. 219
SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy 218
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis 214
Beyond motor neurons: expanding the clinical spectrum in Kennedy's disease 214
A pilot trial with clenbuterol in amyotrophic lateral sclerosis 213
The role of AR polyQ tract in male breast carcinoma: lesson from an SBMA case 213
Activities of mitochondrial complexes correlate with nNOS amount in muscle from ALS patients 212
Clinical and molecular characterization of limb girdle muscular dystrophy due to LAMA2 mutations. 212
Efficacy of Hypnosis-Based Treatment in Amyotrophic Lateral Sclerosis: A Pilot Study 211
Androgen-dependent impairment of myogenesis in spinal and bulbar muscular atrophy. 211
Insights into the genetic epidemiology of SBMA: prevalence estimation and multiple founder haplotypes in the Veneto Italian region. 211
MEF2 impairment underlies skeletal muscle atrophy in polyglutamine disease 210
Survival and quality of life after tracheostomy for acute respiratory failure in patients with amyotrophic lateral sclerosis 207
Brainstem glucose hypermetabolism in ALS/FTD and shorten survival: a 18F-FDG PET/MR study 205
Brain Stem Glucose Hypermetabolism in Amyotrophic Lateral Sclerosis/Frontotemporal Dementia and Shortened Survival: An 18F-FDG PET/MRI Study 204
Empathy-based supportive treatment in amyotrophic lateral sclerosis: A pragmatic study 204
Spinal and bulbar muscular atrophy: skeletal muscle pathology in male patients and heterozygous females. 201
TARDBP (TDP-43) sequence analysis in patients with familial and sporadic ALS: identification of two novel mutations 201
Blood biomarkers for Alzheimer’s disease with the Lumipulse automated platform: Age-effect and clinical value interpretation 198
Activities of mitochondrial complexes correlate with nNOS amount in muscle from ALS patients. 196
Validation of the Italian version of the SBMA Functional Rating Scale as outcome measure 196
NEK1 variants confer susceptibility to amyotrophic lateral sclerosis 195
TDP-43 in skeletal muscle of patients affected with amyotrophic lateral sclerosis 194
Safety and efficacy of edaravone compared to historical controls in patients with amyotrophic lateral sclerosis from North-Eastern Italy 194
Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. 193
Assessment of patients with idiopathic inflammatory myopathies and isolated creatin-kinase elevation 193
Human neural stem cell transplantation in ALS: initial results from a phase I trial 192
The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease 192
Mitochondrial implications in bulbospinal muscular atrophy (Kennedy disease) 190
Clinical and pathological findings in families with X-linked spinal and bulbar muscular atrophy (Kennedy's disease). 190
The Role of Motor System in Mental Rotation: New Insights from Myotonic Dystrophy Type 1 190
Analysis of shared common genetic risk between amyotrophic lateral sclerosis and epilepsy 190
Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS. 187
Nusinersen safety and effects on motor function in adult spinal muscular atrophy type 2 and 3 187
No association of DPP6 with amyotrophic lateral sclerosis in an Italian population. 186
Unilateral calf hypertrophy due to S1-radiculopathy 185
Cardiac function in types II and III spinal muscular atrophy: Should we change standards of care? 185
Skeletal muscle satellite cells in amyotrophic lateral sclerosis 185
A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis. 185
Right hemisphere dysfunction and emotional processing in ALS: an fMRI study 185
PROCEEDINGS OF THE XXI CONGRESS OF THE ITALIAN ASSOCIATION OF MYOLOGY: Digital EditionDecember 01-04, 2021 Neurofilament light chain and Profilin-1 in adult SMA patients under nusinersen treatment: 26-months follow-up 185
Ubiquilin 2 mutations in Italian patients with amyotrophic lateral sclerosis and frontotemporal dementia 184
CAG repeat length in androgen receptor gene is not associated with amyotrophic lateral sclerosis. 183
Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin-1 182
Psychopathological features and suicidal ideation in amyotrophic lateral sclerosis patients. 181
Erythropoietin in amyotrophic lateral sclerosis: A multicentre, randomised, double blind, placebo controlled, phase III study 181
Decoding distinctive features of plasma extracellular vesicles in amyotrophic lateral sclerosis 181
Factors predicting survival in ALS: a multicenter Italian study 177
The MITOS system predicts long-term survival in amyotrophic lateral sclerosis 174
Towards a European Registry and Biorepository for Patients with Spinal and Bulbar Muscular Atrophy 171
null 171
Disruption of skeletal muscle mitochondrial network genes and miRNAs in amyotrophic lateral sclerosis 170
Genetic epidemiology of muscular dystrophies resulting from sarcoglycan gene mutations 169
Genetic variation in KIFAP3 is associated with an upper motor neuron-predominant phenotype in amyotrophic lateral sclerosis 169
Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy. 169
AR cooperates with SMAD4 to maintain skeletal muscle homeostasis 168
Mutational analysis of VCP gene in familial amyotrophic lateral sclerosis 167
Quality of life and motor impairment in ALS: Italian validation of ALSAQ 166
ALS patient ’s death: Psychological impact on the caregiver 166
Transforming growth factor beta 1 signaling is altered in the spinal cord and muscle of amyotrophic lateral sclerosis mice and patients 166
Totale 22.847
Salva come PNG Salva come JPEG
Categoria #
all - tutte 89.345
article - articoli 79.726
book - libri 253
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 339
Totale 169.663
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021418 0 0 0 0 0 0 0 0 0 0 248 170
2021/20222.234 156 249 345 155 65 120 167 198 57 47 247 428
2022/20231.488 310 106 17 168 260 187 2 139 183 18 80 18
2023/2024896 19 98 104 72 75 114 59 63 31 39 106 116
2024/20253.787 29 203 195 157 476 98 196 304 317 174 640 998
2025/202617.896 667 1.255 2.367 2.723 1.780 900 2.173 1.592 2.243 1.225 971 0
Totale 34.564